Author

Elisabetta Todisco

Observed names: E Todisco, E. Todisco, TODISCO, Elisabetta, Todisco Elisabetta, Todisco, Elisabetta, elisabetta Todisco, todisco elisabetta

Institutions: Ospedale di Circolo di Busto Arsizio, Azienda Socio Sanitaria Territoriale della Valle Olona

Observed institutions: St. Jude Children's Research Hospital, Humanitas University, University of Tennessee Health Science Center, Kagawa University, Azienda Ospedaliero-Universitaria delle Marche, Azienda Ospedaliera San Gerardo, Ospedale di Circolo di Busto Arsizio, Kagawa University Hospital, Fondazione Humanitas per la Ricerca, Ospedale Valduce, IRCCS Humanitas Research Hospital, Istituti Ospitalieri di Cremona, Azienda Socio Sanitaria Territoriale della Valle Olona, Azienda Socio Sanitaria Territoriale di Cremona, University of Bari Aldo Moro, European Institute of Oncology, University of Milano-Bicocca, Sapienza University of Rome, University of Bologna

ORCID: 0000-0002-9622-6746

Observed ORCID: 0000-0002-9622-6746

OpenAlex ID: A5018098518

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

2009 · Fabio Ciceri, Chiara Bonini, et al. · The Lancet Oncology · 488

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study

2012 · L. Pagano, C. G. Valentini, et al. · Haematologica · 337

PDF

Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma

2013 · A Raiola, A Dominietto, et al. · Bone Marrow Transplantation · 144

Interleukin-17–Producing T-Helper Cells as New Potential Player Mediating Graft-Versus-Host Disease in Patients Undergoing Allogeneic Stem-Cell Transplantation

2009 · Erica Dander, Adriana Balduzzi, et al. · Transplantation · 130

Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study

2024 · Naval G Daver, Pau Montesinos, et al. · The Lancet Oncology · 74

PDF

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System

2017 · M G Della Porta, C H Jackson, et al. · Leukemia · 74

PDF

Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

2017 · Martino Introna, Federico Lussana, et al. · Transplantation and Cellular Therapy · 66

PDF

Factors affecting successful mobilization with plerixafor: an I talian prospective survey in 215 patients with multiple myeloma and lymphoma

2013 · Francesco Lanza, Roberto M. Lemoli, et al. · Transfusion · 65

Clinical Profile of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

2019 · Naval G. Daver, Pau Montesinos, et al. · Blood · 62

AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia

2023 · Elisabetta Todisco, Cristina Papayannidis, et al. · Cancer · 51

MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis

1998 · M.P. Martelli, M. Martelli, et al. · Annals of Oncology · 49

PDF

Predictive value of early 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high‐dose chemotherapy

2009 · Luca Castagna, Stefania Bramanti, et al. · British Journal of Haematology · 48

PDF

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo

2013 · E Todisco, F Ciceri, et al. · Leukemia · 43

PDF

CD38 ligation inhibits normal and leukemic myelopoiesis

2000 · Elisabetta Todisco, Toshio Suzuki, et al. · Blood · 38

Efficacy and Toxicity of Frontline Ponatinib Plus Blinatumomab for Adult Ph+ ALL Patients of All Ages. Intermediate Analysis of the Gimema ALL2820

2024 · Sabina Chiaretti, Matteo Leoncin, et al. · Blood · 33

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML

2019 · Renato Bassan, Tamara Intermesoli, et al. · Blood Advances · 31

Tandem high‐dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study

2006 · Luca Castagna, Massimo Magagnoli, et al. · American Journal of Hematology · 31

Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

2017 · E Todisco, F Ciceri, et al. · Bone Marrow Transplantation · 30

Real‐world experience with decitabine as a first‐line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy

2019 · Monica Bocchia, Anna Candoni, et al. · Hematological Oncology · 28

Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel)

2016 · Chiara Cattaneo, P. Zappasodi, et al. · Annals of Hematology · 28

Allogeneic Stem Cell Transplantation Compared with Chemotherapy for Poor-Risk Hodgkin Lymphoma

2009 · Luca Castagna, Barbara Sarina, et al. · Transplantation and Cellular Therapy · 28

PDF

CD38 in Hematopoiesis

2000 · D. Campana, T. Suzuki, et al. · KARGER eBooks · 28

1995 · E Todisco, A M Testi, et al. · PubMed · 27

Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study

2023 · Davide Lazzarotto, Ilaria Tanasi, et al. · Annals of Hematology · 26

Reduced‐intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high‐dose chemotherapy and autologous stem cell infusion

2007 · Elisabetta Todisco, Luca Castagna, et al. · European Journal Of Haematology · 26

PDF

Works count: 204

Citation count: 2,685

H-index: 26

I10-index: 54